acebutolol has been researched along with Heart Failure in 10 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the antiarrhythmic efficacy of the new beta adrenergic blocking agent acebutolol, 15 monitored patients with supraventricular arrhythmias received, in double-blind fashion, an intravenous infusion of either acebutolol or saline solution after a control period." | 9.04 | Effective treatment of supraventricular arrhythmias with acebutolol. ( Most, AS; Tatelbaum, R; Williams, DO, 1979) |
| "To evaluate prospectively the impact of carvedilol on a short-term physical training program in stable patients with moderate chronic heart failure (CHF), and to analyze parameters predictive of improvement after training." | 7.71 | Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure. ( Bertrand, P; Charbonnier, B; Forissier, JF; Monpère, C; Vernochet, P, 2001) |
| "To evaluate the antiarrhythmic efficacy of the new beta adrenergic blocking agent acebutolol, 15 monitored patients with supraventricular arrhythmias received, in double-blind fashion, an intravenous infusion of either acebutolol or saline solution after a control period." | 5.04 | Effective treatment of supraventricular arrhythmias with acebutolol. ( Most, AS; Tatelbaum, R; Williams, DO, 1979) |
| "To evaluate prospectively the impact of carvedilol on a short-term physical training program in stable patients with moderate chronic heart failure (CHF), and to analyze parameters predictive of improvement after training." | 3.71 | Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure. ( Bertrand, P; Charbonnier, B; Forissier, JF; Monpère, C; Vernochet, P, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schröder, H | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Ikram, H | 3 |
| Fitzpatrick, D | 2 |
| Hockings, NF | 1 |
| Crozier, IG | 1 |
| Forissier, JF | 1 |
| Vernochet, P | 1 |
| Bertrand, P | 1 |
| Charbonnier, B | 1 |
| Monpère, C | 1 |
| Williams, DO | 1 |
| Tatelbaum, R | 1 |
| Most, AS | 1 |
| Chan, W | 1 |
| Bennett, SI | 1 |
| Bones, PJ | 1 |
| Coumel, P | 2 |
| Hermida, JS | 2 |
| Wennerblöm, B | 1 |
| Leenhardt, A | 1 |
| Maison-Blanche, P | 1 |
| Cauchemez, B | 2 |
| de Jode, P | 1 |
| Jarry, G | 1 |
| Maisonblanche, P | 1 |
| Bernasconi, P | 1 |
1 review available for acebutolol and Heart Failure
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
4 trials available for acebutolol and Heart Failure
| Article | Year |
|---|---|
Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.
Topics: Acebutolol; Administration, Oral; Adult; Cardiomyopathies; Cardiomyopathy, Alcoholic; Cardiomyopathy | 1981 |
Therapeutic controversies with use of beta-adrenoceptor blockade in heart failure.
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; H | 1993 |
Effective treatment of supraventricular arrhythmias with acebutolol.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Double-Blin | 1979 |
[Sinus rhythm and standard deviation in cardiac cycles. Influence of myocardial status and beta-blocker treatment].
Topics: Acebutolol; Cardiomyopathy, Hypertrophic; Circadian Rhythm; Electrocardiography, Ambulatory; Female; | 1989 |
5 other studies available for acebutolol and Heart Failure
| Article | Year |
|---|---|
[Antihypertensive therapy with left cardiac insufficiency].
Topics: Acebutolol; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
Beta-blockers in congestive cardiomyopathy.
Topics: Acebutolol; Cardiac Output; Cardiomegaly; Echocardiography; Heart Failure; Humans | 1981 |
Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Carb | 2001 |
Haemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathy.
Topics: Acebutolol; Adult; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Heart Failure; Heart Rate | 1979 |
Heart rate variability in left ventricular hypertrophy and heart failure, and the effects of beta-blockade. A non-spectral analysis of heart rate variability in the frequency domain and in the time domain.
Topics: Acebutolol; Cardiomegaly; Circadian Rhythm; Electrocardiography, Ambulatory; Female; Heart Failure; | 1991 |